Oisin Biotechnologies logo

Oisin Biotechnologies

Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.

4

Funding Rounds

$7.1m

Money raised

Overview

Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.

Funding series

Funding Series Analysis

The company Oisin Biotechnologies has raised a total of $5m in funding over 4 rounds.

Key Insights:

  • Oisin Biotechnologies Seed round, May 2021: $5m
  • Oisin Biotechnologies Venture Funding Round June 2020: $2.1m
Oisin Biotechnologies logo
Oisin Biotechnologies Seed round, May 2021 $5m
Oisin Biotechnologies logo
Oisin Biotechnologies Venture Funding Round June 2020 $2.1m